HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles AIDS and Behavior Year : 2020

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)

Laure Esterle
Philippe Morlat
  • Function : Author

Abstract

Mortality among individuals co-infected with HIV and hepatitis C virus (HCV) is relatively high. We evaluated the association between psychoactive substance use and both HCV and non-HCV mortality in HIV/HCV co-infected patients in France, using Fine and Gray's competing-risk model adjusted for socio-demographic, clinical predictors and confounding factors, while accounting for competing causes of death. Over a 5-year median follow-up period, 77 deaths occurred among 1028 patients. Regular/daily cannabis use, elevated coffee intake, and not currently smoking were independently associated with reduced HCV-mortality (adjusted sub-hazard ratio [95% CI] 0.28 [0.10-0.83], 0.38 [0.15-0.95], and 0.28 [0.10-0.79], respectively). Obesity and severe thinness were associated with increased HCV-mortality (2.44 [1.00-5.93] and 7.25 [2.22-23.6] versus normal weight, respectively). Regular binge drinking was associated with increased non-HCV-mortality (2.19 [1.10-4.37]). Further research is needed to understand the causal mechanisms involved. People living with HIV/HCV co-infection should be referred for tobacco, alcohol and weight control interventions and potential benefits of cannabis-based therapies investigated.
Fichier principal
Vignette du fichier
AIBE-D-18-01101_HAL.pdf (6.54 Mo) Télécharger le fichier

Dates and versions

inserm-03012682 , version 1 (18-11-2020)

Identifiers

Cite

Melina Erica Santos, Camelia Protopopescu, Philippe Sogni, Issifou Yaya, Lionel Piroth, et al.. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort). AIDS and Behavior, 2020, 24 (4), pp.1069-1084. ⟨10.1007/s10461-019-02585-7⟩. ⟨inserm-03012682⟩
96 View
178 Download

Altmetric

Share

Gmail Facebook X LinkedIn More